Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients.
about
Rationale for the Successful Management of EDTA Chelation Therapy in Human Burden by Toxic MetalsHistorical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease.Chelation therapy in cardiovascular disease: an update.
P2860
Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@ast
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@en
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@nl
type
label
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@ast
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@en
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@nl
prefLabel
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@ast
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@en
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@nl
P2093
P2860
P1476
Chelation therapy and cardiova ...... s to benefit cardiac patients.
@en
P2093
Gervasio A Lamas
Ivan Arenas
Julio G Peguero
P2860
P304
P356
10.1016/J.TCM.2014.06.002
P577
2014-06-12T00:00:00Z